ArticleBiomedicines2023

Impact of Treatment with GLP1 Receptor Agonists, Liraglutide 3.0 mg and Semaglutide 1.0 mg, While on a Waiting List for Bariatric Surgery.

Miguel A Rubio-Herrera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.